Divi’s Labs ‘develops process to make COVID-19 drugs from indigenous inputs’

Divi’s Laboratories has developed a process to manufacture Hydroxychloroquine and Favipiravir, which are used in the treatment of COVID-19, from indig

from The Hindu - Business https://ift.tt/3iqaCFo
via IFTTT